Abortion: Clinical Trials

4 trials for Abortion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Recruiting 2

Follow Abortion: new trials by email Literature Review of Abortion trials Research Report on Abortion

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diphenhydramine as an Adjunct to Moderate Sedation for Procedural First Trimester Abortions
Diphenhydramine, Placebo - Pain, Abortion
Phase 4RecruitingUniversity of Rochester982026-06-292026-08-21
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
Tranexamic Acid, Placebo - Abortion, Dilation and Evacuation
Phase 4RecruitingUniversity of California, San Diego2762025-04-222026-06-15
Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation
Digoxin, Placebo - Abortion
Phase 4CompletedUniversity of California, San Francisco1782017-02-232019-10-30
Propofol-butorphanol Anesthesia During Uterine Curettage
Fentanyl Citrate, Butorphanol Tartrate - Abortion, Curettage
Phase 4CompletedNanjing Medical University1502008-11-012009-07-15

Narrower conditions

Anxiety Disorders (1)  ·  Dilatation, Pathologic (1)  ·  Hemorrhage (1)  ·  Pain (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Anatomical (1)  ·  Signs and Symptoms (1)

Interventions

Butorphanol (1)  ·  Digoxin (1)  ·  Diphenhydramine (1)  ·  Fentanyl (1)  ·  Tranexamic Acid (1)

Sponsors

Nanjing Medical University (1)  ·  University of California, San Diego (1)  ·  University of California, San Francisco (1)  ·  University of Rochester (1)

Countries

United States (3)  ·  China (1)

Top investigators

XiaoFeng Shen, MD (1)